Skip to content

NUTEX HEALTH INC.: 10-K filed 2023-03-03

What NUTEX HEALTH INC. reported in its annual report filed 2023-03-03 (fiscal FY 2022): 49 published measures, 134 facts as tagged in accession 0001558370-23-002713.

This filing

Form
10-K (annual report)
Filed
2023-03-03
Fiscal period
fiscal FY 2022
Accession
0001558370-23-002713 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTEX HEALTH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-12-31431,751,985USD
At 2021-12-31394,650,043USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-12-31311,424,585USD
At 2021-12-31203,069,033USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-12-3195,862,701USD
At 2021-12-31114,651,306USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-12-3134,255,264USD
At 2021-12-3136,118,284USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-10-01 to 2022-12-31-14,752,177USD92
2022-01-01 to 2022-12-31-424,780,446USD365
2021-01-01 to 2021-12-31132,593,328USD365
2020-01-01 to 2020-12-31105,969,885USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-12-3150,607,108USD365
2021-01-01 to 2021-12-31173,432,486USD365
2020-01-01 to 2020-12-3186,671,757USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-12-3114,632,414USD365
2021-01-01 to 2021-12-3136,926,591USD365
2020-01-01 to 2020-12-3161,188,768USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-10-01 to 2022-12-3153,724,073USD92
2022-01-01 to 2022-12-31219,294,306USD365
2021-01-01 to 2021-12-31331,531,311USD365
2020-01-01 to 2020-12-31274,029,061USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-48,132,730USD365
2021-01-01 to 2021-12-31-125,853,033USD365
2020-01-01 to 2020-12-31-7,972,964USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-4,337,398USD365
2021-01-01 to 2021-12-31-36,975,444USD365
2020-01-01 to 2020-12-31-61,188,768USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-12-31-363,285,925USD
At 2021-12-31102,315,623USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-01-01 to 2022-12-31634,877,629shares365
2021-01-01 to 2021-12-31592,791,712shares365
2020-01-01 to 2020-12-31592,791,712shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-10-01 to 2022-12-31-0.02USD/shares92
2022-01-01 to 2022-12-31-0.67USD/shares365
2021-01-01 to 2021-12-310.22USD/shares365
2020-01-01 to 2020-12-310.18USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-10-01 to 2022-12-31-0.02USD/shares92
2022-01-01 to 2022-12-31-0.67USD/shares365
2021-01-01 to 2021-12-310.22USD/shares365
2020-01-01 to 2020-12-310.18USD/shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-10-01 to 2022-12-311,805,176USD92
2022-01-01 to 2022-12-3113,090,905USD365
2021-01-01 to 2021-12-31965,731USD365
2020-01-01 to 2020-12-31181,341USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-12-3182,094,352USD
At 2021-12-31151,912,500USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-12-31189,581USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-10-01 to 2022-12-31-5,778,911USD92
2022-01-01 to 2022-12-31-406,599,154USD365
2021-01-01 to 2021-12-31170,264,898USD365
2020-01-01 to 2020-12-31153,173,887USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-12-3197,973,924USD
At 2021-12-31154,015,179USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-10-01 to 2022-12-312,862,071USD92
2022-01-01 to 2022-12-3112,490,260USD365
2021-01-01 to 2021-12-316,196,026USD365
2020-01-01 to 2020-12-316,432,941USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-12-3154,862,969USD
At 2021-12-3137,690,959USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-12-3123,614,387USD
At 2021-12-3113,582,664USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2022-12-3117,010,637USD
At 2021-12-311,139,297USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-12-3157,777,386USD
At 2021-12-31112,766,317USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-10-01 to 2022-12-316,309,235USD92
2022-01-01 to 2022-12-31420,051,536USD365
2021-01-01 to 2021-12-319,016,060USD365
2020-01-01 to 2020-12-314,432,272USD366

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-12-313,533,285USD
At 2021-12-312,814,178USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-10-01 to 2022-12-31530,324USD92
2022-01-01 to 2022-12-3113,452,382USD365
2021-01-01 to 2021-12-31179,280,958USD365
2020-01-01 to 2020-12-31157,606,159USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-12-31650,223,840shares
At 2021-12-31592,791,712shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-12-31458,498,402USD
At 2021-12-3111,742,891USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2022-12-31120,327,400USD
At 2021-12-31191,581,010USD
At 2020-12-31147,368,825USD
At 2019-12-3150,835,575USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-12-3120,466,632USD
At 2021-12-3121,829,552USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-12-3195,106,230USD
At 2021-12-31163,501,091USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-12-3113,011,878USD
At 2021-12-3111,588,591USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-12-3121,191,390USD
At 2021-12-31682,649USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-12-311,869,806USD
At 2021-12-31323,283USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2022-04-012,400,000USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2022-12-3110,452,211USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-10-01 to 2022-12-31-8,853,408USD92
2022-01-01 to 2022-12-31-419,648,713USD365
2021-01-01 to 2021-12-31169,491,016USD365
2020-01-01 to 2020-12-31145,739,235USD366

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-10-01 to 2022-12-31-10,658,584USD92
2022-01-01 to 2022-12-31-432,739,618USD365
2021-01-01 to 2021-12-31168,525,285USD365
2020-01-01 to 2020-12-31145,557,894USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-10-01 to 2022-12-316,309,235USD92
2022-01-01 to 2022-12-3118,030,832USD365
2021-01-01 to 2021-12-315,462,344USD365
2020-01-01 to 2020-12-314,432,272USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-12-3113,131,374USD365
2021-01-01 to 2021-12-317,662,464USD365
2020-01-01 to 2020-12-315,898,361USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-01-01 to 2022-12-311,159,259USD365
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-310USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-10-01 to 2022-12-31-212,426USD92
2022-01-01 to 2022-12-31-559,299USD365
2021-01-01 to 2021-12-315,422,144USD365
2020-01-01 to 2020-12-31-1,001,711USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2022-01-01 to 2022-12-314,996,209USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-12-314,622,106USD365
2021-01-01 to 2021-12-314,102,167USD365
2020-01-01 to 2020-12-313,254,159USD366

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-12-318,233,000USD365
2021-01-01 to 2021-12-31335,340USD365
2020-01-01 to 2020-12-31181,341USD366

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-01-01 to 2022-12-312,778,767USD365
2021-01-01 to 2021-12-312,302,074USD365
2020-01-01 to 2020-12-311,165,269USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-56,622,133USD365
2021-01-01 to 2021-12-315,392,614USD365
2020-01-01 to 2020-12-3171,234,706USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-31719,107USD365
2021-01-01 to 2021-12-311,088,489USD365
2020-01-01 to 2020-12-31825,773USD366

Inspect the source

Entity
NUTEX HEALTH INC. / CIK 0001479681
Captured
2026-09-20T09:08:51.281Z
SEC response SHA-256
1e4c4278b3e624c66aafe376ea707c33deb0bbd1075a4c39e2ccf48ef8d47252

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001479681.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))